James Zobel

493 total citations
11 papers, 369 citations indexed

About

James Zobel is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, James Zobel has authored 11 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in James Zobel's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Peptidase Inhibition and Analysis (2 papers). James Zobel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Peptidase Inhibition and Analysis (2 papers). James Zobel collaborates with scholars based in United States and Canada. James Zobel's co-authors include Jeffry R. Borgmeyer, Herbert A. Runnels, Thomas W. Powers, Martin F. Jarrold, Bernard N. Violand, Christine E. Smith, Ned R. Siegel, Paul Toren, Charles F. Voliva and Gary Lange and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Chromatography A.

In The Last Decade

James Zobel

11 papers receiving 352 citations

Peers

James Zobel
Hau B. Nguyen United States
Bill Brizzard United States
Kalavathy Sitaraman United States
Mark B. Carter United States
Carolina E. Caffaro United States
Ioana L. Aanei United States
James Zobel
Citations per year, relative to James Zobel James Zobel (= 1×) peers Genoveva Nacheva

Countries citing papers authored by James Zobel

Since Specialization
Citations

This map shows the geographic impact of James Zobel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Zobel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Zobel more than expected).

Fields of papers citing papers by James Zobel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Zobel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Zobel. The network helps show where James Zobel may publish in the future.

Co-authorship network of co-authors of James Zobel

This figure shows the co-authorship network connecting the top 25 collaborators of James Zobel. A scholar is included among the top collaborators of James Zobel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Zobel. James Zobel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Powers, Thomas W., et al.. (2021). Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors. Molecular Therapy — Methods & Clinical Development. 23. 254–262. 88 indexed citations
2.
Thorn, Jennifer M., Keshab Bhattacharya, Justin B. Sperry, et al.. (2017). The Effect of Physicochemical Modification on the Function of Antibodies Induced by Anti-Nicotine Vaccine in Mice. Vaccines. 5(2). 11–11. 14 indexed citations
3.
Li, Gang, Lianglin Zhang, Enhong Chen, et al.. (2010). Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity. Cancer Research. 70(24). 10243–10254. 20 indexed citations
4.
Lightle, Sandra, Serdar Aykent, Nathan A. Lacher, et al.. (2010). Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding. Protein Science. 19(4). 753–762. 23 indexed citations
5.
Runnels, Herbert A., Gregory L. Weber, Jing Min, et al.. (2010). PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases. Advances in Therapy. 27(3). 168–180. 20 indexed citations
6.
Hall, Troii, Kam F. Fok, James Zobel, et al.. (2007). A high performance liquid chromatography assay for monitoring proprotein convertase activity. Journal of Chromatography A. 1148(1). 46–54. 3 indexed citations
7.
Parthasarathy, R., Edwin Rowold, Gary Lange, et al.. (2004). Biochemical and Immunological Properties of Cytokines Conjugated to Dendritic Polymers. Biomedical Microdevices. 6(3). 191–202. 38 indexed citations
8.
Lee, Stephen C., Ranjani V. Parthasarathy, James Zobel, et al.. (2001). Recognition Properties of Antibodies to PAMAM Dendrimers and Their Use in Immune Detection of Dendrimers. Biomedical Microdevices. 3(1). 53–59. 21 indexed citations
9.
Violand, Bernard N., Michael R. Schlittler, Paul Toren, et al.. (1992). Isolation and characterization of porcine somatotropin containing a succinimide residue in place of aspartate129. Protein Science. 1(12). 1634–1641. 34 indexed citations
10.
Borgmeyer, Jeffry R., et al.. (1992). Isolation and characterization of a 22 kDa protein with antifungal properties from maize seeds. Biochemical and Biophysical Research Communications. 182(1). 1–5. 92 indexed citations
11.
Violand, Bernard N., B. D. Vineyard, Ned R. Siegel, et al.. (1991). Determination of the disulfide bond pairings in bovine transforming growth factor‐α. International journal of peptide & protein research. 37(6). 463–467. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026